Boston Scientific (NYSE:BSX – Get Free Report) released its earnings results on Wednesday. Boston Scientific updated its Q3 2026 guidance to 0.800-0.820 EPS and its FY 2026 guidance to 3.280-3.320 EPS. Boston Scientific Price PerformanceNYSE BSX traded up $0.52 on Wednesday, hitting $46.58. Garton & Associates Financial Advisors LLC purchased a new stake in Boston Scientific in the fourth quarter valued at approximately $26,000. Featured StoriesReceive News & Ratings for Boston Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific and related companies with MarketBeat.com's FREE daily email newsletter.